Nutex Health, Inc.
Price Action
Technical Summary
EMERGING TRENDNutex Health, Inc. is attempting to emerge into an uptrend but lacks full moving average alignment. Relative strength is leading (RS Rating: 90), indicating clear outperformance against the broad market. Earnings growth of 155% provides fundamental context to the price action. However, price is extended 28% above the 50-day line, increasing the risk of a mean reversion.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $141.30 | +17.77% | ABOVE |
| 50 SMA | $129.59 | +28.41% | ABOVE |
| 100 SMA | $115.88 | +43.60% | ABOVE |
| 150 SMA | $130.28 | +27.72% | ABOVE |
| 200 SMA | $124.68 | +33.47% | ABOVE |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is NUTX in an uptrend right now?
NUTX has a trend score of 3/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 3 of 4 trend criteria are met.
Is NUTX overbought or oversold?
NUTX's RSI (14) is 63. The stock is in neutral territory, neither overbought nor oversold.
Is NUTX outperforming the market?
NUTX has a Relative Strength (RS) Rating of 90 out of 99. Yes, NUTX is a market leader, outperforming 90% of all stocks over the past 12 months.
Where is NUTX in its 52-week range?
NUTX is trading at $166.40, which is 86% of its 52-week high ($193.07) and 77% above its 52-week low ($77.21).
How volatile is NUTX?
NUTX has a Beta of 1.87 and 52-week volatility of 94%. It's more volatile than the S&P 500 - expect bigger swings.